https://www.businesswire.com/news/home/20190116005281/en/

LYON, France & NEW YORK--(BUSINESS WIRE)--Jan 16, 2019--The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, today announced full year 2018 sales.

Medicrea closed the 2018 financial year on a very positive trend by achieving the best fourth quarter in its history. Sales were 8.0 million euros, up 30% compared to the 4 th quarter of the previous year. In the United States, sales increased by 27%, driven by a sharp acceleration in the number of personalized UNiD™ surgeries since the second half of the year.